FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2113561246> ?p ?o ?g. }

• W2113561246 endingPage "328" @default.
• W2113561246 startingPage "320" @default.
• W2113561246 abstract "Introduction New direct oral anticoagulants (NOACs) constitute a novel treatment option for acute venous thromboembolism (VTE), with practical advantages. Individual studies have demonstrated comparable efficacy to that of vitamin K antagonists (VKAs) and have suggested a more favorable safety profile . We performed a meta-analysis to determine the efficacy and safety of NOACs as compared with those of VKAs in patients with acute VTE. Methods We searched MEDLINE, EMBASE, the Cochrane Database of Systematic Reviews and the Clinical Trials Registry up to October 2013. Eligible studies included phase 3 trials comparing NOACs with VKAs in patients with acute VTE. Relative risks (RRs), absolute risk differences and numbers needed to treat (NNTs) to prevent one event were calculated for recurrent VTE, fatal pulmonary embolism (PE), overall mortality, major bleeding, and other bleeding complications, with random-effects models. Results Five studies were included, investigating four NOACs (rivaroxaban, dabigatran, apixaban, and edoxaban) in 24 455 patients with acute VTE. RRs for recurrent VTE, fatal PE and overall mortality for NOACs vs. VKAs were 0.88 (95% confidence interval [CI] 0.74–1.05), 1.02 (95% CI 0.39–5.96), and 0.97 (95% CI 0.83–1.14), respectively. The RR for major bleeding was 0.60 (95% CI 0.41–0.88). The NNT with NOACs instead of VKA to prevent one major bleed was 149. The RR and NNT for fatal bleeding were 0.36 (95% CI 0.15–0.87) and 1111. A fixed-effect network analysis did not demonstrate significant differences between individual NOACs and rivaroxaban. Conclusions NOACs have comparable efficacy to that of VKAs, and are associated with a significantly lower risk of bleeding complications, although the NNT to prevent one major bleed was relatively high." @default.
• W2113561246 created "2016-06-24" @default.
• W2113561246 creator A5010807373 @default.
• W2113561246 creator A5026613773 @default.
• W2113561246 creator A5052585650 @default.
• W2113561246 creator A5057323541 @default.
• W2113561246 creator A5069014026 @default.
• W2113561246 creator A5086859453 @default.
• W2113561246 date "2014-03-01" @default.
• W2113561246 modified "2023-10-05" @default.
• W2113561246 title "Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta‐analysis" @default.
• W2113561246 cites W1974462736 @default.
• W2113561246 cites W1976437213 @default.
• W2113561246 cites W1987751327 @default.
• W2113561246 cites W2007680892 @default.
• W2113561246 cites W2028762958 @default.
• W2113561246 cites W2035077408 @default.
• W2113561246 cites W2067741035 @default.
• W2113561246 cites W2071869524 @default.
• W2113561246 cites W2076621544 @default.
• W2113561246 cites W2083426277 @default.
• W2113561246 cites W2088052643 @default.
• W2113561246 cites W2101863341 @default.
• W2113561246 cites W2112378432 @default.
• W2113561246 cites W2115787552 @default.
• W2113561246 cites W2115841978 @default.
• W2113561246 cites W2118092611 @default.
• W2113561246 cites W2125957676 @default.
• W2113561246 cites W2129225854 @default.
• W2113561246 cites W2130199362 @default.
• W2113561246 cites W2135918458 @default.
• W2113561246 cites W2137567338 @default.
• W2113561246 cites W2139511461 @default.
• W2113561246 cites W2158662386 @default.
• W2113561246 cites W2166402206 @default.
• W2113561246 cites W2189476799 @default.
• W2113561246 cites W2481569543 @default.
• W2113561246 cites W2989714602 @default.
• W2113561246 doi "https://doi.org/10.1111/jth.12485" @default.
• W2113561246 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24330006" @default.
• W2113561246 hasPublicationYear "2014" @default.
• W2113561246 type Work @default.
• W2113561246 sameAs 2113561246 @default.
• W2113561246 citedByCount "407" @default.
• W2113561246 countsByYear W21135612462014 @default.
• W2113561246 countsByYear W21135612462015 @default.
• W2113561246 countsByYear W21135612462016 @default.
• W2113561246 countsByYear W21135612462017 @default.
• W2113561246 countsByYear W21135612462018 @default.
• W2113561246 countsByYear W21135612462019 @default.
• W2113561246 countsByYear W21135612462020 @default.
• W2113561246 countsByYear W21135612462021 @default.
• W2113561246 countsByYear W21135612462022 @default.
• W2113561246 countsByYear W21135612462023 @default.
• W2113561246 crossrefType "journal-article" @default.
• W2113561246 hasAuthorship W2113561246A5010807373 @default.
• W2113561246 hasAuthorship W2113561246A5026613773 @default.
• W2113561246 hasAuthorship W2113561246A5052585650 @default.
• W2113561246 hasAuthorship W2113561246A5057323541 @default.
• W2113561246 hasAuthorship W2113561246A5069014026 @default.
• W2113561246 hasAuthorship W2113561246A5086859453 @default.
• W2113561246 hasConcept C120195587 @default.
• W2113561246 hasConcept C126322002 @default.
• W2113561246 hasConcept C142454548 @default.
• W2113561246 hasConcept C177713679 @default.
• W2113561246 hasConcept C2776265017 @default.
• W2113561246 hasConcept C2776301958 @default.
• W2113561246 hasConcept C2778661090 @default.
• W2113561246 hasConcept C2778810321 @default.
• W2113561246 hasConcept C2779161974 @default.
• W2113561246 hasConcept C2780290652 @default.
• W2113561246 hasConcept C2780638905 @default.
• W2113561246 hasConcept C44249647 @default.
• W2113561246 hasConcept C67774102 @default.
• W2113561246 hasConcept C71924100 @default.
• W2113561246 hasConcept C82789193 @default.
• W2113561246 hasConcept C95190672 @default.
• W2113561246 hasConceptScore W2113561246C120195587 @default.
• W2113561246 hasConceptScore W2113561246C126322002 @default.
• W2113561246 hasConceptScore W2113561246C142454548 @default.
• W2113561246 hasConceptScore W2113561246C177713679 @default.
• W2113561246 hasConceptScore W2113561246C2776265017 @default.
• W2113561246 hasConceptScore W2113561246C2776301958 @default.
• W2113561246 hasConceptScore W2113561246C2778661090 @default.
• W2113561246 hasConceptScore W2113561246C2778810321 @default.
• W2113561246 hasConceptScore W2113561246C2779161974 @default.
• W2113561246 hasConceptScore W2113561246C2780290652 @default.
• W2113561246 hasConceptScore W2113561246C2780638905 @default.
• W2113561246 hasConceptScore W2113561246C44249647 @default.
• W2113561246 hasConceptScore W2113561246C67774102 @default.
• W2113561246 hasConceptScore W2113561246C71924100 @default.
• W2113561246 hasConceptScore W2113561246C82789193 @default.
• W2113561246 hasConceptScore W2113561246C95190672 @default.
• W2113561246 hasIssue "3" @default.
• W2113561246 hasLocation W21135612461 @default.
• W2113561246 hasLocation W21135612462 @default.
• W2113561246 hasOpenAccess W2113561246 @default.
• W2113561246 hasPrimaryLocation W21135612461 @default.

• next